DCI Partners
Tokyodaiwa-inv.co.jp
Overview
DCI Partners is a venture capital firm based in Tokyo, Japan, that specializes in the life sciences, biotechnology, and drug discovery sectors with a focus on investments in Japan and Taiwan.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rege Nephro Co., Ltd. | Jul 2026 | Debt | Co-investor |
| Neusignal Therapeutics, Inc. | Jun 2026 | Series B | Lead |
| SCOHIA PHARMA, Inc. | May 2026 | VC Round | Co-investor |
| Apeximmune Therapeutics | Mar 2025 | Series A | Co-investor |
| Rege Nephro Co., Ltd. | Oct 2024 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
